1-Acetyl-N-[1-(2-phenylethyl)piperidin-4-yl]-indolin-5-amine, 95.0%, 5g

6-Methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, 95.0%, 5g

TERT-BUTYL 6-(HYDROXYMETHYL)-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE, 95.0%, 25g

2-Bromo-6-methylbenzonitrile, 95.0%, 25g

1,4-Bis(benzo[d]oxazol-2-yl)naphthalene, 98.0%, 100g

MPEP, 97%, 250mg

N-CYCLOHEXYL-N-METHYL-4-(1,2-DIHYDRO-2-OXO-6-QUINOLYLOXY)BUTYRAMIDE, 95%, 1g

Methyl 2,6-Dichloroisonicotinate, 97.0%, 10g

4-Chlorobenzoic acid, >=98%, for synthesis, 250 g, plastic packaging.

1-Chloro-3-(methylsulfanyl)propane, 97%, 250mg

3-(4-methylpiperidin-1-yl)propan-1-ol, 95.0%, 1g

3-(4-(2-Methoxyethyl)phenoxy)propane-1,2-diol, 97%, 250mg

N,N'-Diphenyl-1,4-phenylenediamine>95.0%(T)25g